126
Participants
Start Date
December 31, 2014
Primary Completion Date
May 31, 2015
Study Completion Date
September 30, 2015
Favipiravir
"Group A1: Day-0 (inclusion), h0: 2400 mg; h8: 2400 mg; h16: 1200 mg. Day-1 to Day-9: 1200 mg bid.~Group A2: Day-0 (inclusion), h0: 2400 mg; h8: 2400 mg; h16: 1200 mg. Day-1 to Day-9: 1200 mg bid.~Group C: daily dosages will be adapted to their body weight."
The caregivers treatment center, Conakry
MSF Ebola treatment centre, Gueckedou
French Red Cross Ebola care center, Macenta
ALIMA Ebola care center, Nzérékoré
Institut National de la Santé Et de la Recherche Médicale, France
OTHER_GOV